newsfilter
← Latest News
GlobeNewswire·

Arch Biopartners Announces GMP Manufacturing of Cilastatin Drug Product

TORONTO, June 27, 2024 (GLOBE NEWSWIRE) -- Arch Biopartners Inc., ("Arch" or the "Company") (TSXV:ARCH, OTCQB:ACHFF), announced that Dalton Pharma Services (Dalton) has completed the good manufacturing practice (GMP)